EC Number   |
Specific Activity Minimum [µmol/min/mg] |
Specific Activity Maximum [µmol/min/mg] |
Reference |
|---|
   3.4.11.9 | -999 |
- |
- |
36044, 36050, 36051, 36054, 652158 |
| 3.4.11.9 | -999 |
- |
continuous spectrometric assay |
36042 |
| 3.4.11.9 | -999 |
- |
the supernatant shows a specific activity of the recombinant enzyme of 117 units/mg, the cell-free extract shows a specific activity of the recombinant enzyme of 8 units/mg |
701061 |
| 3.4.11.9 | 0.016 |
- |
humans with previous angiotensin-converting enzyme-inhibitor treatment-associated angio-oedema |
653085 |
| 3.4.11.9 | 0.022 |
0.023 |
humans without angiotensin-converting enzyme-inhibitor treatment-associated angio-oedema |
653085 |
| 3.4.11.9 | 0.0375 |
- |
recombinant wild-type enzyme, substrate bradykinin |
649942 |
| 3.4.11.9 | 0.17 |
- |
mutant R404A, pH 7.5, 37°C |
667712 |
| 3.4.11.9 | 0.21 |
- |
- |
36039 |
| 3.4.11.9 | 0.95 |
- |
mutant R404A, presence of guanidine, pH 7.5, 37°C |
667712 |
| 3.4.11.9 | 1.343 |
- |
- |
36047 |
